“Treatment with DT56a resulted in a significant reduction of hot flushes in postmenopausal women… observed within the first month of treatment.”

A prospective study of DT56a (Femarelle®) for the treatment of menopause symptoms.


A statistically significant (p < 0.01) reduction in the number and intensity of hot flushes was
experienced after 2 and 4 weeks of DT56atreatment. After 4 weeks of treatment
with DT56a, 80.7% of the patients reported that their hot flushes were ‘better’ or ‘much
better’. The severity of hot flushes was also reduced by 38% in all study participants and by
36% in women who had experienced more than seven hot flushes per day initially, before

Contact Us


TruLife Distribution
401 E. Las Olas Blvd Suite 1400
Fort Lauderdale, Florida

* The products and the claims made about specific products on or through the Website have not been evaluated by the United States Food and Drug Administration (not required) and are not intended to diagnose, treat, cure or prevent disease. The information provided on this Site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this Website for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional, and carefully read all information provided on or in any product label or packaging, before using any medication or nutritional, herbal or homeopathic product (including regarding any interactions between any medication you are currently taking and such products), before starting any treatment for a health problem, or if you have or suspect you might have a health problem. Unless advised by your healthcare professional, biological age should not be used to determine or alter any age-related health or medical treatments based on your chronological age.